The expressions of matrix metalloproteinase-9, estrogen receptor, and progesterone receptor in thin endometrial tissue and their significance
Other
OA: bronze
CC0
⤵ 2 in-corpus citations
AI-generated summary
This study found that refractory thin endometrium is associated with reduced endometrial glands and significantly lower ER and MMP-9 expressions compared to normal endometrium.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
OBJECTIVE: This study aims to investigate the expressions of matrix metalloproteinase-9 (MMP-9), estrogen receptor (ER), and progesterone receptor (PR) in thin endometrium.
METHODS: Patients who received treatment in our hospital between January 2018 and September 2020 were enrolled. Endometrial thickness was measured using transvaginal ultrasound; in patients with a midluteal phase endometrial thickness of <7 mm, a sample of endometrial tissue was obtained using a hysteroscope, and the MMP-9, ER, and PR expressions were detected using immunohistochemistry. In addition, the number of endometrial glands was calculated in a complete field of view under a low-power (100×) microscope, and the serum estrogen and progesterone levels were determined. Following hormone therapy, the midluteal phase endometrial thickness was measured again using transvaginal ultrasound, and the patients were divided into two groups: the thin endometrium group and the normal endometrium group (n = 50, each). Patients in the thin endometrium group had an endometrial thickness of <7 mm, while patients in the normal endometrium group had an endometrial thickness of 7-10 mm.
RESULTS: The number of endometrial glands as well as the ER and MMP-9 expressions were lower in the thin endometrium group than in the normal endometrium group; the differences were statistically significant (p < .05). The receiver operator characteristic curve revealed that ER and MMP-9 had a high prediction accuracy in patients with refractory thin endometrium, while the number of endometrial glands was moderately predictive.
CONCLUSION: Compared with other patients with thin endometrium, patients with refractory thin endometrium had a reduced the number of endometrial glands and significantly lower ER and MMP-9 expressions.
My notes (saved in your browser only)
MeSH descriptors
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (4)
- Single-cell transcriptomic analysis of eutopic endometrium and ectopic lesions of adenomyosis 2021
- Genetic and epigenetic changes in the eutopic endometrium of women with endometriosis: association with decreased endometrial αvβ3 integrin expression 2021
- PI3K, AKT, and P-AKT levels in thin endometrium 2016
- Correction to: Aberrant Expression of Sodium-Potassium-Chloride Cotransporter in Endometriosis 2021
Cited by (2)
References (17)
- Correction to: Aberrant Expression of Sodium-Potassium-Chloride Cotransporter in Endometriosis via openalex
- Genetic and epigenetic changes in the eutopic endometrium of women with endometriosis: association with decreased endometrial αvβ3 integrin expression via openalex
- PI3K, AKT, and P-AKT levels in thin endometrium via openalex
- Single-cell transcriptomic analysis of eutopic endometrium and ectopic lesions of adenomyosis via openalex
- doi:10.4103/0974-1208.178632 via openalex
- doi:10.3389/fendo.2019.00061 via openalex
- doi:10.1097/gco.0000000000000173 via openalex
- doi:10.1007/s10815-019-01407-y via openalex
- doi:10.1053/j.semdp.2010.09.002 via openalex
- doi:10.1186/s13567-020-00891-w via openalex
- doi:10.1210/endocr/bqab054 via openalex
- doi:10.1097/md.0000000000019111 via openalex
- doi:10.3168/jds.2020-19554 via openalex
- doi:10.1093/molehr/gaz068 via openalex
- doi:10.1038/nprot.2009.191 via openalex
- doi:10.1016/j.msec.2018.04.025 via openalex
- doi:10.3389/fendo.2018.00776 via openalex
Cited by (2)
Source provenance
- openalex
- last seen: 2026-05-10T11:04:01.855261+00:00
- pubmed
- last seen: 2026-10-08T21:34:55.717994+00:00
License: CC0
· commercial use OK